Table 5.
Prevalence of MAFLD and its subgroups in quartile groups of different indexes [n(%)].
| FLI | χ2 | P | Cramer’s V | ||||
|---|---|---|---|---|---|---|---|
| F1 (n=265) | F2 (n=264) | F3 (n=264) | F4 (n=265) | ||||
| MAFLD | 27 (10.19) | 137 (51.89) a | 213 (80.68) ab | 244 (92.08) abc | 436.655 | <0.01 | 0.642 |
| non-MAFLD | 238 (89.81) | 127 (48.11) a | 51 (19.32) ab | 21 (7.92) abc | |||
| OR | 9.509 * | 36.815 * | 102.420 * | ||||
| adjusted OR | 12.830 * | 49.884 * | 149.589 * | ||||
| LAP | |||||||
| L1 (n=265) | L2 (n=264) | L3 (n=264) | L4 (n=265) | ||||
| Obesity MAFLD | 21 (7.92) | 125 (47.35) a | 165 (62.50) ab | 153 (57.74) abc | 175.858 | <0.01 | 0.498 |
| Obesity non-MAFLD | 89 (33.58) | 95 (35.98) a | 44 (16.67) ab | 16 (6.04) abc | |||
| OR | 5.576 * | 15.893 * | 40.527 * | ||||
| adjusted OR | 5.521 * | 15.461 * | 39.894 * | ||||
| WTI | |||||||
| W1 (n=265) | W2 (n=264) | W3 (n=264) | W4 (n=265) | ||||
| Lean MAFLD | 3 (1.13) | 8 (3.03) a | 19 (7.20) ab | 6 (2.26) ab | 78.098 | <0.01 | 0.645 |
| Lean non-MAFLD | 111 (41.89) | 29 (10.98) a | 11 (4.17) ab | 1 (0.38) ab | |||
| OR | 10.207 * | 63.909 * | 222.000 * | ||||
| adjusted OR | 12.980 * | 82.272 * | 221.349 * | ||||
| FLI | |||||||
| F1 (n=265) | F2 (n=264) | F3 (n=264) | F4 (n=265) | ||||
| T2DM MAFLD | 2 (0.75) | 5 (1.89) | 22 (8.33) ab | 92 (34.72) abc | 97.985 | <0.01 | 0.778 |
| T2DM non-MAFLD | 20 (7.55) | 13 (4.92) | 6 (2.27) ab | 2 (0.75) abc | |||
| OR | 3.846 | 36.667 * | 460.000 * | ||||
| adjusted OR | 4.962 | 70.418 * | 321.323 * | ||||
The correlations between the indexes and MAFLD groups in quartile groups were analyzed by univariate and multivariate logistic regression. Data were expressed as number (percentage) and analyzed by chi-square test for categorical variables.
compared with quartile 1 of predictors, *P < 0.05; compared with quartile 1 of predictors, aP < 0.05; compared with quartile 2 of predictors, bP < 0.05; compared with quartile 3 of predictors, cP <0.05.
adjusted OR: the values of ORs after adjusting for age and gender in FLI and WTI or age in LAP.
MAFLD, metabolic dysfunction-associated fatty liver disease; OR, odds ratio; T2DM, type 2 diabetes mellitus; FLI, fatty liver index; LAP, lipid accumulation product; WTI, waist circumference-triglyceride index.